• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

MYF-01-37

CAS No. 2416417-65-5

MYF-01-37 ( 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one )

产品货号. M24113 CAS No. 2416417-65-5

MYF-01-37 is a novel covalent TEAD inhibitor.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥275 有现货
5MG ¥446 有现货
10MG ¥786 有现货
25MG ¥1442 有现货
50MG ¥2535 有现货
100MG ¥3791 有现货
500MG ¥7995 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    MYF-01-37
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    MYF-01-37 is a novel covalent TEAD inhibitor.
  • 产品描述
    MYF-01-37 is a novel covalent TEAD inhibitor.
  • 同义词
    1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    TEAD
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2416417-65-5
  • 分子量
    298.3
  • 分子式
    C15H17F3N2O
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    CC(CC1)(CN1C(C=C)=O)Nc1cccc(C(F)(F)F)c1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Kurppa K J , Liu Y , To C , et al. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway[J]. Cancer Cell, 2020, 37(1):104-122.e12.
产品手册
关联产品
  • TES-1025

    TES-1025 is an effective and selective inhibitor of human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (IC50: 13 nM).

  • ML-336

    ML-336 is an inhibitor of of the Venezuelan equine encephalitis virus (VEEV) strain TC-83.

  • PKC ζ pseudosubstrat...

    Inhibitor of protein kinase C (PKC) ζ; attached to cell permeabilisation Antennapedia domain vector peptide. Consists of amino acids 113 - 129 of PKC ζ pseudosubstrate domain linked by a disulphide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the inhibitor peptide. Once inside the cell, the disulphide bonds are subjected to reduction in the cytoplasm leading to release of the inhibitor peptide. Induces mast cell degranulation by a PKC ζ-independent pathway.